Edwards Lifesciences Financials

Edwards Lifesciences Stock Summary

Edwards Lifesciences competes with GRUPO CARSO, Direct Line, CREDIT AGRICOLE, Chiba Bank, and CARSALESCOM. Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12800 people.

Edwards Lifesciences Key Financial Ratios

There are many critical financial ratios that Edwards Lifesciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Edwards Lifesciences reports annually and quarterly.

Edwards Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Edwards Lifesciences's current stock value. Our valuation model uses many indicators to compare Edwards Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Edwards Lifesciences competition to find correlations between indicators driving Edwards Lifesciences's intrinsic value. More Info.Edwards Lifesciences is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about  0.51  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Edwards Lifesciences is roughly  1.96 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Edwards Lifesciences' earnings, one of the primary drivers of an investment's value.

Edwards Lifesciences Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Edwards Lifesciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Edwards Lifesciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Edwards Lifesciences based on widely used predictive technical indicators. In general, we focus on analyzing Edwards Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Edwards Lifesciences's daily price indicators and compare them against related drivers.

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.